Transcatheter Aortic Valve Replacement for Aortic Stenosis
Transcatheter Aortic Valve Replacement (TAVR) is a treatment option for aortic stenosis. Aortic stenosis is a common heart problem affecting approximately one million patients in the U.S. each year. TAVR is an innovative, minimally invasive
option for intermediate and high-risk patients. In 2005, Beaumont was the first hospital in North America to perform this procedure.
The aortic valve regulates blood flow from the left ventricle, the main pump of the heart, to the aorta and entire body.
Aortic stenosis is a mechanical problem caused by calcium accumulation in the aortic valve. The narrowing of the valve leads to reduced blood flow to the body and increased strain on
the left ventricle. Ultimately, this leads to symptoms including shortness of breath, chest discomforts and fainting. Left untreated, severe aortic stenosis can lead to death in up to 50 percent of patients.